Alembic Pharma surges on USFDA completing inspection at its Bioequivalence facility

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 520.00, up by 9.65 points or 1.89% from its previous closing of Rs. 510.35 on the BSE. The scrip opened at Rs. 520.00 and has touched a high and low of Rs. 525.80 and Rs. 517.15 respectively. The BSE group ‘A’ stock of face value Rs. 2 has … Read more

BREAKING NEWS:
WhatsApp Chats to Auto-Delete: Activate This Feature! Exciting July: New Maruti, Kia, and Royal Enfield Launches! Bajaj Chetak sales surge 126%, 113KM for ₹25!